• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SynBa:一种具有不确定性量化的药物组合协同作用的改进估计方法。

SynBa: improved estimation of drug combination synergies with uncertainty quantification.

机构信息

Department of Computer Science and Technology, University of Cambridge, Cambridge CB3 0FD, United Kingdom.

Health Data Research UK, London NW1 2BE, United Kingdom.

出版信息

Bioinformatics. 2023 Jun 30;39(39 Suppl 1):i121-i130. doi: 10.1093/bioinformatics/btad240.

DOI:10.1093/bioinformatics/btad240
PMID:37387161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10311304/
Abstract

MOTIVATION

There exists a range of different quantification frameworks to estimate the synergistic effect of drug combinations. The diversity and disagreement in estimates make it challenging to determine which combinations from a large drug screening should be proceeded with. Furthermore, the lack of accurate uncertainty quantification for those estimates precludes the choice of optimal drug combinations based on the most favourable synergistic effect.

RESULTS

In this work, we propose SynBa, a flexible Bayesian approach to estimate the uncertainty of the synergistic efficacy and potency of drug combinations, so that actionable decisions can be derived from the model outputs. The actionability is enabled by incorporating the Hill equation into SynBa, so that the parameters representing the potency and the efficacy can be preserved. Existing knowledge may be conveniently inserted due to the flexibility of the prior, as shown by the empirical Beta prior defined for the normalized maximal inhibition. Through experiments on large combination screenings and comparison against benchmark methods, we show that SynBa provides improved accuracy of dose-response predictions and better-calibrated uncertainty estimation for the parameters and the predictions.

AVAILABILITY AND IMPLEMENTATION

The code for SynBa is available at https://github.com/HaotingZhang1/SynBa. The datasets are publicly available (DOI of DREAM: 10.7303/syn4231880; DOI of the NCI-ALMANAC subset: 10.5281/zenodo.4135059).

摘要

动机

存在一系列不同的量化框架来估计药物组合的协同效应。由于估计值的多样性和不一致性,很难确定应该对大量药物筛选中的哪些组合进行进一步研究。此外,由于缺乏对这些估计值的准确不确定性量化,因此无法根据最有利的协同效应来选择最佳的药物组合。

结果

在这项工作中,我们提出了 SynBa,这是一种灵活的贝叶斯方法,可以估计药物组合协同疗效和效力的不确定性,以便可以从模型输出中得出可行的决策。通过将 Hill 方程纳入 SynBa,可以保留表示效力和功效的参数,从而实现了可操作性。由于先验的灵活性,可以方便地插入现有知识,如为归一化最大抑制作用定义的经验 Beta 先验。通过对大型组合筛选实验和与基准方法的比较,我们表明 SynBa 提供了更准确的剂量反应预测,以及对参数和预测更好的校准不确定性估计。

可用性和实现

SynBa 的代码可在 https://github.com/HaotingZhang1/SynBa 上获得。数据集是公开可用的(DREAM 的 DOI:10.7303/syn4231880;NCI-ALMANAC 子集的 DOI:10.5281/zenodo.4135059)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/810944cb0ff5/btad240f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/1e78a92a6f1f/btad240f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/097026d5064b/btad240f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/fcc43b356ff7/btad240f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/1d21e5e3a442/btad240f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/2ad3088e0e6f/btad240f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/810944cb0ff5/btad240f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/1e78a92a6f1f/btad240f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/097026d5064b/btad240f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/fcc43b356ff7/btad240f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/1d21e5e3a442/btad240f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/2ad3088e0e6f/btad240f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24cd/10311304/810944cb0ff5/btad240f6.jpg

相似文献

1
SynBa: improved estimation of drug combination synergies with uncertainty quantification.SynBa:一种具有不确定性量化的药物组合协同作用的改进估计方法。
Bioinformatics. 2023 Jun 30;39(39 Suppl 1):i121-i130. doi: 10.1093/bioinformatics/btad240.
2
Uncertainty quantification, propagation and characterization by Bayesian analysis combined with global sensitivity analysis applied to dynamical intracellular pathway models.贝叶斯分析与全局敏感性分析相结合对动态细胞内途径模型进行不确定性量化、传播和特征描述。
Bioinformatics. 2019 Jan 15;35(2):284-292. doi: 10.1093/bioinformatics/bty607.
3
Advanced error modeling and Bayesian uncertainty quantification in mechanistic liquid chromatography modeling.机理液相色谱建模中的高级误差建模与贝叶斯不确定性量化
J Chromatogr A. 2023 Oct 11;1708:464329. doi: 10.1016/j.chroma.2023.464329. Epub 2023 Aug 24.
4
A Bayesian approach to targeted experiment design.贝叶斯方法在目标实验设计中的应用。
Bioinformatics. 2012 Apr 15;28(8):1136-42. doi: 10.1093/bioinformatics/bts092. Epub 2012 Feb 24.
5
Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets.大规模稀疏药物组合数据集的协同作用的统计评估和可视化。
BMC Bioinformatics. 2019 Feb 18;20(1):83. doi: 10.1186/s12859-019-2642-7.
6
Optimizing representations for integrative structural modeling using Bayesian model selection.利用贝叶斯模型选择优化整合结构建模的表示。
Bioinformatics. 2024 Mar 4;40(3). doi: 10.1093/bioinformatics/btae106.
7
BayeStab: Predicting effects of mutations on protein stability with uncertainty quantification.BayeStab:使用不确定性量化预测突变对蛋白质稳定性的影响。
Protein Sci. 2022 Nov;31(11):e4467. doi: 10.1002/pro.4467.
8
A Bayesian active learning platform for scalable combination drug screens.用于可扩展联合药物筛选的贝叶斯主动学习平台。
Nat Commun. 2025 Jan 2;16(1):156. doi: 10.1038/s41467-024-55287-7.
9
Efficient gradient-based parameter estimation for dynamic models using qualitative data.利用定性数据进行动态模型的高效基于梯度的参数估计。
Bioinformatics. 2021 Dec 7;37(23):4493-4500. doi: 10.1093/bioinformatics/btab512.
10
Bayesian estimation of community size and overlap from random subsamples.贝叶斯估计群落大小和重叠的随机抽样。
PLoS Comput Biol. 2022 Sep 19;18(9):e1010451. doi: 10.1371/journal.pcbi.1010451. eCollection 2022 Sep.

引用本文的文献

1
A continuous epistasis model for predicting growth rate given combinatorial variation in gene expression and environment.一种用于预测基因表达和环境组合变化下生长速率的连续上位性模型。
Cell Syst. 2024 Feb 21;15(2):134-148.e7. doi: 10.1016/j.cels.2024.01.003. Epub 2024 Feb 9.

本文引用的文献

1
Effective drug combinations in breast, colon and pancreatic cancer cells.在乳腺癌、结肠癌和胰腺癌细胞中有效的药物组合。
Nature. 2022 Mar;603(7899):166-173. doi: 10.1038/s41586-022-04437-2. Epub 2022 Feb 23.
2
Non-parametric synergy modeling of chemical compounds with Gaussian processes.基于高斯过程的化合物非参数协同建模。
BMC Bioinformatics. 2022 Jan 6;23(1):14. doi: 10.1186/s12859-021-04508-7.
3
MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery.MuSyC 是一个共识框架,它统一了组合药物发现的多药物协同作用指标。
Nat Commun. 2021 Jul 29;12(1):4607. doi: 10.1038/s41467-021-24789-z.
4
bayesynergy: flexible Bayesian modelling of synergistic interaction effects in in vitro drug combination experiments.贝叶斯协同:体外药物组合实验中协同相互作用效应的灵活贝叶斯建模。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab251.
5
Modeling drug combination effects via latent tensor reconstruction.通过潜在张量重构来模拟药物组合效应。
Bioinformatics. 2021 Jul 12;37(Suppl_1):i93-i101. doi: 10.1093/bioinformatics/btab308.
6
Dose-response modeling in high-throughput cancer drug screenings: an end-to-end approach.高通量癌症药物筛选中的剂量反应建模:端到端方法。
Biostatistics. 2022 Apr 13;23(2):643-665. doi: 10.1093/biostatistics/kxaa047.
7
Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects.利用多向相互作用系统地预测临床前药物组合效应。
Nat Commun. 2020 Dec 1;11(1):6136. doi: 10.1038/s41467-020-19950-z.
8
synergy: a Python library for calculating, analyzing and visualizing drug combination synergy.协同作用:一个用于计算、分析和可视化药物组合协同作用的 Python 库。
Bioinformatics. 2021 Jun 16;37(10):1473-1474. doi: 10.1093/bioinformatics/btaa826.
9
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen.社区评估在药物基因组筛选中推进癌症药物组合的计算预测。
Nat Commun. 2019 Jun 17;10(1):2674. doi: 10.1038/s41467-019-09799-2.
10
DrugComb: an integrative cancer drug combination data portal.DrugComb:一个综合性的癌症药物组合数据库。
Nucleic Acids Res. 2019 Jul 2;47(W1):W43-W51. doi: 10.1093/nar/gkz337.